Triplepoint Venture Growth BDC is an asset management business based in the US. Triplepoint Venture Growth BDC shares (TPVG) are listed on the NYSE and all prices are listed in US Dollars. Its last market close was $8.04 – an increase of 1.77% over the previous week.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $8.04 |
|---|---|
| 52-week range | $6.44 - $10.22 |
| 50-day moving average | $7.06 |
| 200-day moving average | $8.52 |
| Wall St. target price | $7.83 |
| PE ratio | 40.2 |
| Dividend yield | $1.5 (14.93%) |
| Earnings per share (TTM) | $0.20 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $7.95 from 2024-11-20
| 1 week (2024-11-15) | 0.63% |
|---|---|
| 1 month (2024-10-23) | 19.19% |
| 3 months (2024-08-22) | 6.57% |
| 6 months (2024-05-22) | -15.43% |
| 1 year (2023-11-22) | -24.00% |
|---|---|
| 2 years (2022-11-22) | -17.10% |
| 3 years (2021-11-22) | 12.6941 |
| 5 years (2019-11-22) | 1.40% |
Valuing Triplepoint Venture Growth BDC stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Triplepoint Venture Growth BDC's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Triplepoint Venture Growth BDC's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 40x. In other words, Triplepoint Venture Growth BDC shares trade at around 40x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Triplepoint Venture Growth BDC's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.6875. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Triplepoint Venture Growth BDC's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
| Revenue TTM | $115.3 million |
|---|---|
| Operating margin TTM | 79.39% |
| Gross profit TTM | $119.3 million |
| Return on assets TTM | 6.36% |
| Return on equity TTM | 2.83% |
| Profit margin | 9.05% |
| Book value | $9.10 |
| Market Capitalization | $322 million |
TTM: trailing 12 months
Dividend payout ratio: 96.15% of net profits
Recently Triplepoint Venture Growth BDC has paid out, on average, around 100% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Triplepoint Venture Growth BDC shareholders could enjoy a 0% return on their shares, in the form of dividend payments. In Triplepoint Venture Growth BDC's case, that would currently equate to about $1.5 per share.
Triplepoint Venture Growth BDC's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.
Triplepoint Venture Growth BDC's most recent dividend payout was on 26 December 2024. The latest dividend was paid out to all shareholders who bought their shares by 12 December 2024 (the "ex-dividend date").
Over the last 12 months, Triplepoint Venture Growth BDC's shares have ranged in value from as little as $6.441 up to $10.2181. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Triplepoint Venture Growth BDC's is 1.803. This would suggest that Triplepoint Venture Growth BDC's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
TriplePoint Venture Growth BDC Corp. is a business development company specializing investments in venture capital-backed companies at the growth stage investments. It also provides debt financing to venture growth space companies which includes growth capital loans, secured and customized loans, equipment financings, revolving loans and direct equity investments. The fund seeks to invest in e-commerce, entertainment, technology and life sciences sector. Within technology the areas of focus include: Security, wireless communication equipments, network system and software, business applications software, conferencing equipments/services . big data, cloud computing, data storage, electronics, energy efficiency, hardware, information services, internet and media, networking, semiconductors, software, software as a service, and other technology related subsectors and within life sciences the areas of focus include: biotechnology, bio fuels/bio mass, diagnostic testing and bioinformatics, drug delivery, drug discovery, healthcare information systems, healthcare services, medical, surgical and therapeutic devices, pharmaceuticals and other life science related subsectors. Within growth capital loans it invests between $5 million and $50 million, for equipment financings it invests between $5 million and $25 million, for revolving loans it invests between $1 million and $25 million, and for direct equity investments it may invest between $0.
Some of the best paper trading apps to practice stock trading with fake money include Interactive Brokers, eToro, Charles Schwab and more.
Want to buy and sell international stocks? Here are the top brokers to help you trade global markets.
These are the best discount brokers of 2024 according to Finder’s comprehensive review.
The best platforms to use for automatic investing include Wealthfront, SoFi, Schwab, Vanguard, Titan, Acorns and more. See our full list here.
We’ve rounded up stats on some of the most popular graphene stocks, along with information on how they compare and how to invest.
5 Betterment robo-advisor alternatives to consider when building your portfolio.
What you need to know about investing in the leading indicator for the overall US stock market.
How do you gift stocks to loved ones? Learn the ins and outs of finding the right investments for them.
Check out the best-performing ETFs so far in 2024.
Acorns is a financial service that rounds up your purchases and turns the extra change into investments.